CRSP Competitors & Alternatives
Compare Crispr Therapeutics AG with similar stocks in the same industry
Biotechnology
CRSP
Main Stock$50.63
Tradestie Score
50
Market Cap
$6.02B
Revenue Growth
0.7%
Analyst Upside
+67.3%
Top Competitors
231 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABVX
Abivax SA American Depositary Shares
|
$135.98
|
$6.38B | - | 58 | Compare |
|
LEGN
Legend Biotech Corporation American Depositary Shares
|
$25.75
|
$6.03B | - | 45 | Compare |
|
NUVL
Nuvalent, Inc. Class A Common Stock
|
$123.94
|
$5.95B | - | 58 | Compare |
|
AXSM
Axsome Therapeutics, Inc
|
$228.28
|
$5.92B | - | 51 | Compare |
|
TGTX
TG Therapeutics, Inc.
|
$55.01
|
$5.80B | 20.0 | 59 | Compare |
|
KRYS
Krystal Biotech, Inc. Common Stock
|
$363.44
|
$5.20B | 49.0 | 59 | Compare |
|
PCVX
Vaxcyte, Inc. Common Stock
|
$57.03
|
$4.94B | - | 63 | Compare |
|
PTCT
PTC Therapeutics, Inc.
|
$81.33
|
$4.93B | - | 53 | Compare |
|
ARWR
Arrowhead Research Corporation
|
$74.11
|
$4.84B | - | 43 | Compare |
|
ACLX
Arcellx, Inc. Common Stock
|
$115.07
|
$4.55B | - | 57 | Compare |
More CRSP Analysis
Data updated: Jul 13, 2026 | Industry: Biotechnology (SIC 2836)
231 stocks in this industry